galantamine

(redirected from Galantamine hydrobromide)
Also found in: Medical.

ga·lan·tam·ine

 (gə-lăn′tə-mēn′)
n.
A drug, C17H21NO3, originally derived from the bulbs of snowdrops and other plants, that inhibits the action of acetylcholinesterase and is used in its hydrobromide form to treat dementia in people with Alzheimer's disease.

[Formed on the model of Russian galantamin : New Latin Galanthus, snowdrop genus name (coined by Carl Linnaeus in reference to the milk-white flowers of the snowdrop : Greek gala, milk; see melg- in Indo-European roots + Greek anthos, flower) + amine.]

galantamine

(ɡəˈlæntəˌmiːn)
n
(Pharmacology) a drug that, by blocking the action of the enzyme acetylcholinesterase in the cortex of the brain, has been used to slow down the cognitive decline that characterizes Alzheimer's disease
Translations

galantamine

n galantamina
References in periodicals archive ?
AChE from Electrophorus electricus, BChE from equine serum and galantamine hydrobromide were purchased from Sigma (St.
Canadian health authorities have issued a public advisory concerning the safety of galantamine hydrobromide as a treatment for mild cognitive impairment--an off-label use.
Galantamine hydrobromide (CAS 1953-04-4) Market Research Report 2012 presents comprehensive data on galantamine hydrobromide markets globally and regionally (Europe, Asia, North America etc.
Roxane Laboratories' Galantamine Hydrobromide Oral Solution is AA rated to RAZADYNE (galantamine hydrobromide).
has received approval today from the United States Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for galantamine hydrobromide extended-release capsules, eq.
The decision allows FDA-approved generic versions of immediate-release galantamine hydrobromide to enter the U.
Food and Drug Administration to manufacture and market Galantamine Hydrobromide Tablets, 4mg (base), 8mg (base), and 12mg (base).